Tag: Incremental innovation

Over 60% of the drugs on the World Health Organization's essential medicines list are classified as 'me-too' drugs, highlighting their widespread prevalence in healthcare. The question of whether these follow-on medications are justified, however, continues to be a contentious topic in the fields of pharmacology and pharmaceutical ethics.

According to the World Health Organization (WHO), over 60% of the drugs on its essential medicines list are me-too drugs. This statistic highlights the common but often misunderstood presence of these follow-on pharmaceuticals in modern medicine, raising important questions about their value and purpose.